Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer-Reference-Cited by-同舟云学术

Cervical cancer geographical burden analyzer: An interactive, open-access tool for understanding geographical disease burden in patients with recurrent or metastatic cervical cancer

Published:2023-02 Issue: Volume:169 Page:113-117
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Castellano Tara,Moore Kathleen,Ting Jie,Washington Christina,Yildiz Yasin,Surinach Andy,Sonawane Kalyani,Chhatwal Jagpreet,Ayer Turgay

Funder

Seagen

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference25 articles.

1. Cancer Stat Facts: Cervical Cancer;National Cancer Insititute,2022

2. The impact of systemic therapy beyond first-line treatment for advanced cervical Cancer;McLachlan;Clin Oncol (R Coll Radiol).,2017

3. Management of patients with recurrent/advanced cervical cancer beyond first line platinum regimens: where do we stand? A literature review;Boussios;Crit. Rev. Oncol. Hematol.,2016

4. Chemotherapy for advanced and recurrent cervical carcinoma: results from cooperative group trials;Leath;Gynecol. Oncol.,2013

5. ENGOT-cx11/KEYNOTE-A18: a phase III, randomized, double-blind study of pembrolizumab with chemoradiotherapy in patients with high-risk locally advanced cervical cancer;Lorusso;J. Clin. Oncol.,2020

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Health disparities in cervical cancer: Estimating geographic variations of disease burden and association with key socioeconomic and demographic factors in the US;PLOS ONE;2024-07-18

2. Assessing Geographic Variation in Rates of Cervical Cancer and Recurrent or Metastatic Cervical Cancer Among Medicaid Enrollees;American Journal of Clinical Oncology;2023-07-17

3. Dynamics of Medical Screening: A Simulation Model of PSA Screening for Early Detection of Prostate Cancer;Systems;2023-05-16

4. Targeting our efforts: the contribution of an open-access tool to assess geographic distribution of recurrent and metastatic cervical cancer;Gynecologic Oncology;2023-02